切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2013, Vol. 02 ›› Issue (03) : 129 -133. doi: 10.3877/cma.j.issn.2095-3216.2013.03.005

专家论坛

血液净化治疗急性肾损伤的新认识
刘文虎1,()   
  1. 1.100050 北京,首都医科大学附属北京友谊医院肾内科
  • 出版日期:2013-06-15
  • 通信作者: 刘文虎

New realization of blood purification therapy in acute kidney injury

Wen-hu LIU1,()   

  1. 1.Department of Nephrology, Affiliated Beijing Friendship Hospital, Capital Medical University, Beijing 100050,China
  • Published:2013-06-15
  • Corresponding author: Wen-hu LIU
引用本文:

刘文虎. 血液净化治疗急性肾损伤的新认识[J/OL]. 中华肾病研究电子杂志, 2013, 02(03): 129-133.

Wen-hu LIU. New realization of blood purification therapy in acute kidney injury[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2013, 02(03): 129-133.

急性肾损伤(AKI)是临床常见的急危重症,可由多种原因诱发,常导致患者死亡或肾功能的丧失。血液净化是治疗AKI的重要手段,它不仅是一种肾脏替代技术,在重症患者中更发挥着多器官功能支持的作用。及时给予合理剂量的血液净化治疗,关乎患者的生存率、肾功能的恢复和预后。但目前对于不同的AKI患者应该选择哪种血液净化模式,何时开始和终止治疗以及给予多大的治疗剂量等问题仍存在较多争议。现就近年来关于AKI患者血液净化治疗的新认识和新进展做一综述。

Acute kidney injury (AKI) induced by a variety of reasons is a common acute and severe clinical syndrome, which often leads to loss of renal function or death of the patients. Blood purification is frequently supplied in the treatment of AKI. It is not only a kind of renal replacement technology, but also plays a supporting role for multiple organ functions in critically ill patients. Giving the reasonable dosage of blood purification in time closely correlates to the survival of patients and recovery of renal function as well as their prognosis. But for different AKI patients, there are still many disputes about the blood purification models, the treatment doses, and when to start or terminate the treatment. In this review, we discuss the new realization and progress about blood purification therapy for AKI patients.

1
Hoste EA, Kellum JA. RIFLE criteria provide robust assessment of kidney dysfunction and correlate with hospital mortality [J].Crit Care Med, 2006, 34(7): 2016-2017.
2
Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001 [J]. Am J Kidney Dis, 2005, 45(1): 96-101.
3
Chertow GM, Burdick E, Honour M, et al. Acute kidney injury,mortality, length of stay, and costs in hospitalized patients [J]. J Am Soc Nephrol, 2005, 16(11): 3365-3370.
4
Wu VC, Ko WJ, Chang HW, et al. Early renal replacement therapy in patients with postoperative acute liver failure associated with acute renal failure: effect on postoperative outcomes [J]. J Am Coll Surg, 2007, 205(2): 266-276.
5
Jacka MJ, Ivancinova X, Gibney RT. Continuous renal replacement therapy improves renal recovery from acute renal failure [J]. Can J Anaesth, 2005, 52(3): 327-332.
6
Rabindranath K, Adams J, Macleod AM, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults [J/CD]. Cochrane Database Syst Rev, 2007, (3):CD003773.
7
Lin CM, Lin JW, Tsai JT, et al. Intracranial pressure fluctuation during hemodialysis in renal failure patients with intracranial hemorrhage [J]. Acta Neurochir Suppl, 2008, 101: 141-144.
8
Lins RL, Elseviers MM, Van der Niepen P, et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial [J]. Nephrol Dial Transplant, 2009,24(2): 512-518.
9
De Smedt DM, Elseviers MM, Lins RL, et al. Economic evaluation of different treatment modalities in acute kidney injury[J]. Nephrol Dial Transplant, 2012, 27(11): 4095-4101.
10
Fieghen HE, Friedrich JO, Burns KE, et al. The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury [J].BMC Nephrol, 2010, 11: 32.
11
Oh HJ, Park JT, Kim JK, et al. Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy [J].Nephrol Dial Transplant, 2012, 27(2): 589-594.
12
Sugahara S, Suzuki H. Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery [J]. Hemodial Int, 2004, 8(4):320-325.
13
Heung M, Wolfgram DF, Kommareddi M, et al. Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury [J]. Nephrol Dial Transplant, 2012, 27(3): 956-961.
14
Shiao CC, Wu VC, Li WY, et al. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery [J]. Crit Care, 2009,13(5): R171.
15
Shiao CC, Ko WJ, Wu VC, et al. U-curve association between timing of renal replacement therapy initiation and in-hospital mortality in postoperative acute kidney injury [J]. PLoS One,2012, 7(8): e42952.
16
Vats HS, Dart RA, Okon TR, et al. Does early initiation of continuous renal replacement therapy affect outcome: experience in a tertiary care center [J]. Ren Fail, 2011, 33(7): 698-706.
17
Uchino S, Bellomo R, Morimatsu H, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study [J]. Crit Care Med,2009, 37(9): 2576-2582.
18
Boussekey N, Chiche A, Faure K, et al. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock [J]. Intensive Care Med, 2008, 34(9): 1646-1653.
19
Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial [J]. Lancet, 2000,356(9223): 26-30.
20
Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury [J]. N Engl J Med, 2008, 359(1): 7-20.
21
Bellomo R, Cass A, Cole L, et al. Intensity of continuous renalreplacement therapy in critically ill patients [J]. N Engl J Med,2009, 361(17): 1627-1638.
22
Bonventre JV. Dialysis in acute kidney injury--more is not better[J]. N Engl J Med, 2008, 359(1): 82-84.
23
Wu VC, Ko WJ, Chang HW, et al. Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy[J]. Intensive Care Med, 2008, 34(1): 101-108.
[1] 张婧琦, 江洋, 孙佳璐, 唐兴喆, 赵宇飞, 崔颖, 李信响, 戴景月, 傅琳, 彭新桂. 基于肾周CT特征结合血清肌酐水平探讨脓毒症伴急性肾损伤的早期识别[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 285-292.
[2] 樊恒, 孙敏, 朱建华. 红景天苷通过抑制PI3K/AKT/mTOR信号通路对大鼠脓毒症急性肾损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 188-195.
[3] 张锦丽, 席毛毛, 褚志刚, 栾夏刚, 陈诺, 王德运, 谢卫国. 大面积烧伤患者发生早期急性肾损伤的危险因素分析[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 282-287.
[4] 彭瑞, 杨瑞文, 魏澹宁, 夏永良. 琥珀酸受体1加重肾脏缺血再灌注损伤的作用研究[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 159-164.
[5] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国肝移植受者肾损伤管理临床实践指南(2023版)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 276-288.
[6] 杜霞, 马梦青, 曹长春. 造影剂诱导的急性肾损伤的发病机制及干预靶点研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 279-282.
[7] 郭俊楠, 林惠, 任艺林, 乔晞. 氨基酸代谢异常在急性肾损伤向慢性肾脏病转变中的作用研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 283-287.
[8] 袁楠, 黄梦杰, 白云凤, 李晓帆, 罗从娟, 陈健文. 急性肾损伤-慢性肾脏病转化小鼠模型制备的教学要点及学习效果分析[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 226-230.
[9] 林玲, 李京儒, 沈瑞华, 林惠, 乔晞. 基于生物信息学分析小鼠急性肾损伤和急性肺损伤的枢纽基因[J/OL]. 中华肾病研究电子杂志, 2024, 13(03): 134-144.
[10] 邱英鹏, 李欣雨, 邱海波, 刘松桥, 张凌, 于湘友, 秦秉玉, 蒲莹莹, 赵佳钰, 刘永军, 肖月, 杨毅. 连续性肾脏替代治疗质量控制指标体系的建立及验证[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 351-357.
[11] 向阳, 史黎炜, 肖月, 邱海波, 杨毅, 刘松桥, 邱英鹏, 张莹. 连续性肾脏替代治疗在我国五地区重症医学科的效率分析[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 358-363.
[12] 赵佳钰, 邱英鹏, 刘松桥, 杨毅, 张凌, 于湘友, 秦秉玉, 邱海波, 史黎炜, 刘克军, 蒲莹莹, 陈子扬, 赵羽西, 刘永军, 肖月. 连续性肾脏替代治疗在我国五地区重症医学科的应用现况[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 364-374.
[13] 司楠, 孙洪涛. 创伤性脑损伤后肾功能障碍危险因素的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 300-305.
[14] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要